Nutex Health (NUTX) Stock Forecast & Price Target
Score
Nutex Health, Inc. price target
| NUTX | |
|---|---|
| Low | $310.00 |
| Average | $310.00 |
| High | $310.00 |
| Upside vs current price | +78.5% |
The average target of $310.00 is +78.5% versus the current NUTX price of $173.67.
Nutex Health, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
6 analysts cover NUTX.
Nutex Health, Inc. EPS and revenue estimates
Published annual figures for NUTX on this page are 2026 EPS $27.37, 2027 EPS $27.32. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $27.37 | $870.47M |
| 2027 | $27.32 | $959.75M |
Is Nutex Health, Inc. a buy or sell?
Of the 6 analysts covering Nutex Health, Inc., 6 rate it a buy (1 strong buy and 5 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The NUTX consensus label is Buy, beside 6 buy-side ratings and 0 sell-side ratings.
The average target of $310.00 implies +78.5% versus the current price of $173.67.
The NUTX rating block is 6 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the Nutex Health, Inc. forecast
the Nutex Health, Inc. has a tight target cluster: $310.00 to $310.00, average $310.00.
The gap from the $173.67 price to the NUTX average is +78.5%.
The NUTX rating mix is lopsided rather than split: 6 of 6 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.
the Nutex Health, Inc. has a flat EPS path, $27.37 for 2026 and $27.32 for 2027.
With 6 analysts on NUTX, the average is a small sample.
Nutex Health, Inc. forecast questions
What is the NUTX price target?
The published range for NUTX is $310.00 to $310.00, with an average of $310.00. That average is +78.5% versus the current price of $173.67.
Is Nutex Health, Inc. a buy or sell?
Of the 6 analysts covering Nutex Health, Inc., 6 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving NUTX at 6 buy ratings, 0 holds, and 0 sells.
What is the EPS estimate for Nutex Health, Inc.?
Analyst EPS estimates for Nutex Health, Inc.: 2026 $27.37, 2027 $27.32.
What is the revenue estimate for Nutex Health, Inc.?
Analyst revenue estimates for Nutex Health, Inc.: 2026 $870.47M, 2027 $959.75M.
How many analysts cover NUTX?
6 analysts cover NUTX. Their consensus on NUTX is Buy, across those 6.